SCHEMBL23129882

SCHEMBL23129882

CCOC(O)c1cccc2c1OB(O)[C@@H](NC(=O)CCS(=O)(=O)NC)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19228048 0.89 — —
SCHEMBL19662835 0.86 MTNR1A (0.31) —
SCHEMBL23837412 0.86 CYP1A2 (0.30) —
SCHEMBL23129909 0.85 MTNR1A (0.31) —
SCHEMBL18797964 0.85 MEN1 (0.32) —
SCHEMBL18797989 0.84 MTNR1A (0.32) —
SCHEMBL21539671 0.84 — —
SCHEMBL18797981 0.83 MTNR1A (0.32) —
SCHEMBL23129663 0.82 TSHR (0.33) —
SCHEMBL17347664 0.82 TSHR (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3154989-B1 BETA-LACTAMASE INHIBITORS VENATORX PHARMACEUTICALS INC (US) 2021-03-24 — — EP disclosed
Send feedback